Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.

Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, Charles P, Dastmalchi M, Lundberg IE.

Medicine (Baltimore). 2012 Jul;91(4):206-11. doi: 10.1097/MD.0b013e318260977c. Review.

2.

Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.

Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M.

Arthritis Rheum. 2006 Jun;54(6):2004-9.

3.

Antibody to threonyl-transfer RNA synthetase in myositis sera.

Targoff IN, Arnett FC, Reichlin M.

Arthritis Rheum. 1988 Apr;31(4):515-24.

PMID:
3128989
4.

Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.

Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, Casciola-Rosen L, Hong G, Dellaripa PF, Highland KB.

Chest. 2009 Jun;135(6):1550-6. doi: 10.1378/chest.08-2233. Epub 2009 Feb 18. Review.

PMID:
19225060
5.

Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.

Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.

Intern Med J. 2011 Sep;41(9):674-9. doi: 10.1111/j.1445-5994.2010.02164.x. Epub 2010 Jan 4.

PMID:
20059602
6.

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.

PLoS One. 2013;8(4):e60442. doi: 10.1371/journal.pone.0060442. Epub 2013 Apr 3.

7.

Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies.

Sato S, Hirakata M, Kuwana M, Nakamura K, Suwa A, Inada S, Mimori T, Ikeda Y.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):609-15.

PMID:
16173235
8.

Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.

Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Hachulla E, Vittecoq O, Menard JF, Jouen F, Dominique S.

Eur J Intern Med. 2013 Jul;24(5):474-9. doi: 10.1016/j.ejim.2013.01.002. Epub 2013 Feb 1.

PMID:
23375620
9.

Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.

Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN.

Arthritis Rheum. 2007 Apr;56(4):1295-303.

10.

Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.

Labirua-Iturburu A, Selva-O'Callaghan A, Martínez-Gómez X, Trallero-Araguás E, Labrador-Horrillo M, Vilardell-Tarrés M.

Clin Exp Rheumatol. 2013 May-Jun;31(3):436-9. Epub 2013 Mar 7.

PMID:
23465087
11.

Myositis-related interstitial lung disease and antisynthetase syndrome.

Solomon J, Swigris JJ, Brown KK.

J Bras Pneumol. 2011 Jan-Feb;37(1):100-9. Review. English, Portuguese.

12.

Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.

Hall JC, Casciola-Rosen L, Samedy LA, Werner J, Owoyemi K, Danoff SK, Christopher-Stine L.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1307-15. doi: 10.1002/acr.21992.

13.
14.

Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias.

Watanabe K, Handa T, Tanizawa K, Hosono Y, Taguchi Y, Noma S, Kobashi Y, Kubo T, Aihara K, Chin K, Nagai S, Mimori T, Mishima M.

Respir Med. 2011 Aug;105(8):1238-47. doi: 10.1016/j.rmed.2011.03.022. Epub 2011 Apr 22.

15.

Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.

Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B, Lechtzin N, Mammen AL, Casciola-Rosen L, Christopher-Stine L, Danoff SK.

Respir Med. 2014 Oct;108(10):1542-8. doi: 10.1016/j.rmed.2014.09.003. Epub 2014 Sep 18.

PMID:
25269710
16.

Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies.

Tomonaga M, Sakamoto N, Ishimatsu Y, Kakugawa T, Harada T, Nakashima S, Hara A, Hara S, Horai Y, Kawakami A, Mukae H, Kohno S.

Lung. 2015 Feb;193(1):79-83. doi: 10.1007/s00408-014-9665-7. Epub 2014 Nov 14.

PMID:
25394672
17.

Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody.

Mathews MB, Reichlin M, Hughes GR, Bernstein RM.

J Exp Med. 1984 Aug 1;160(2):420-34.

18.

[The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].

Szabó K, Nagy-Vincze M, Bodoki L, Hodosi K, Dankó K, Griger Z.

Orv Hetil. 2016 Apr 10;157(15):575-83. doi: 10.1556/650.2016.30400. Hungarian.

PMID:
27039996
19.

[Myositis-specific autoantibodies].

Fujimoto M.

Brain Nerve. 2013 Apr;65(4):449-60. Review. Japanese.

PMID:
23568993
20.
Items per page

Supplemental Content

Write to the Help Desk